U.S. patent application number 15/669637 was filed with the patent office on 2017-11-16 for methods and apparatus for transpericardial left atrial appendage closure.
The applicant listed for this patent is SentreHEART, Inc.. Invention is credited to Jordan T. BAJOR, Aaron V. KAPLAN.
Application Number | 20170325819 15/669637 |
Document ID | / |
Family ID | 23225194 |
Filed Date | 2017-11-16 |
United States Patent
Application |
20170325819 |
Kind Code |
A1 |
KAPLAN; Aaron V. ; et
al. |
November 16, 2017 |
METHODS AND APPARATUS FOR TRANSPERICARDIAL LEFT ATRIAL APPENDAGE
CLOSURE
Abstract
Methods and apparatus for closing a left atrial appendage are
described. The methods rely on introducing a closure tool from a
location beneath the rib cage, over an epicardial surface, and to
the exterior of the left atrial appendage. The closure device may
then be used to close the left atrial appendage, preferably at its
base, by any one of a variety of techniques. A specific technique
using graspers and a closing loop is illustrated.
Inventors: |
KAPLAN; Aaron V.; (Los
Altos, CA) ; BAJOR; Jordan T.; (Palo Alto,
CA) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
SentreHEART, Inc. |
Redwood City |
CA |
US |
|
|
Family ID: |
23225194 |
Appl. No.: |
15/669637 |
Filed: |
August 4, 2017 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
14604632 |
Jan 23, 2015 |
9724105 |
|
|
15669637 |
|
|
|
|
11944522 |
Nov 23, 2007 |
8974473 |
|
|
14604632 |
|
|
|
|
10105978 |
Mar 25, 2002 |
7318829 |
|
|
11944522 |
|
|
|
|
10007364 |
Nov 5, 2001 |
7226458 |
|
|
10105978 |
|
|
|
|
09315601 |
May 20, 1999 |
6488689 |
|
|
10007364 |
|
|
|
|
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
A61B 2017/320048
20130101; A61B 17/10 20130101; A61B 17/12 20130101; A61B 17/122
20130101; A61B 2017/00243 20130101; A61B 17/12013 20130101; A61B
17/1285 20130101 |
International
Class: |
A61B 17/12 20060101
A61B017/12; A61B 17/10 20060101 A61B017/10; A61B 17/128 20060101
A61B017/128; A61B 17/122 20060101 A61B017/122 |
Claims
1. A method for closing a left atrial appendage of a patient's
heart, said method comprising: positioning a closure instrument
through a percutaneous passage beneath the rib cage, over an
epicardial surface, and adjacent to the left atrial appendage; and
closing the left atrial appendage using the closure instrument.
2. A method as in claim 1, wherein positioning comprises advancing
a distal end of the closure instrument through an access sheath,
into the pericardial space, and over an epicardial surface to an
atrioventricular groove of the heart.
3. A method as in claim 2, wherein closing comprises looping,
suturing, stapling, clipping, riveting, clamping, or fusing the
left atrial appendage at a neck region thereof.
4. A method as in claim 3, wherein closing further comprises
grasping the left atrial appendage prior to closing the neck region
thereof.
5. A method as in claim 1, wherein the method is performed while
the patient's heart is beating.
6. A method as in claim 5, wherein the method is performed while
both lungs of the patient remain inflated.
7. A method as in claim 6, wherein the method is performed while
the patient is under a local anesthetic.
8. A kit comprising: a closure device; and instructions for use
setting forth a method as in claim 1.
9. A method as in claim 1, further comprising separating a parietal
pericardium from a visceral pericardium near left atrial appendage
prior to closing the left atrial appendage to create a space over
the atrial appendage.
10. A method as in claim 9, further comprising viewing the atrial
appendage through the space.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] The present application is a continuation of U.S. patent
application Ser. No. 11/944,522, filed Nov. 23, 2007, which is a
continuation of U.S. patent application Ser. No. 10/105,978, filed
Mar. 25, 2002, which issued as U.S. Pat. No. 7,318,829 on Jan. 15,
2008, which is a divisional of U.S. patent application Ser. No.
10/007,364, filed Nov. 5, 2001, which issued as U.S. Pat. No.
7,226,458 on Jun. 5, 2007, which is a divisional of U.S. patent
application Ser. No. 09/315,601, filed May 20, 1999, which issued
as U.S. Pat. No. 6,488,689 on Dec. 3, 2002.
BACKGROUND OF THE INVENTION
Field of the Invention
[0002] The present invention relates generally to medical methods
and apparatus. More particularly, the present invention relates to
a method and device for the minimally invasive closure of a left
atrial appendage of the heart.
[0003] Atrial fibrillation is a common cardiac rhythm disorder
affecting a population of approximately 2.5 million patients in the
United States alone. Atrial fibrillation results from a number of
different causes and is characterized by a rapid chaotic heart
beat. In addition to the risks associated with a disordered heart
beat, patients with atrial fibrillation also have an increased risk
of stroke. It has been estimated that approximately 75,000 atrial
fibrillation patients each year suffer a stroke related to that
condition. It appears that strokes in these patients result from
emboli many of which may originate from the left atrial appendage.
The irregular heart beat causes blood to pool in the left atrial
appendage, allowing clots to accumulate over time. From time to
time, clot may dislodge from the left atrial appendage and may
enter the cranial circulation causing a stroke, the coronary
circulation causing a myocardial infarction, the peripheral
circulation causing limb ischemia, as well as other vascular
beds.
[0004] Significant efforts have been made to reduce the risk of
stroke in patients suffering from atrial fibrillation. Most
commonly, those patients are treated with blood thinning agents,
such as coumadin, to reduce the risk of clot formation. While such
treatment can significantly reduce the risk of stroke, it also
increases the risk of bleeding and for that reason is inappropriate
for many atrial fibrillation patients.
[0005] As an alternative to drug therapy, surgical procedures for
closing the left atrial appendage have been proposed. Most
commonly, the left atrial appendage has been closed or removed in
open surgical procedures, typically where the heart has stopped and
the chest opened through the sternum. Because of the significant
risk and trauma of such procedures, left atrial appendage removal
occurs almost exclusively when the patient's chest is opened for
other procedures, such as coronary artery bypass or valve
surgery.
[0006] For that reason, alternative procedures which do not require
opening of the patient's chest, i.e., a large median sternotomy,
have been proposed. U.S. Pat. No. 5,306,234 to Johnson describes a
thoroscopic procedure where access to the pericardial space over
the heart is achieved using a pair of intercostal penetrations
(i.e., penetrations between the patient's ribs) to establish both
visual and surgical access. While such procedures may be performed
while the heart remains beating, they still require deflation of
the patient's lung sad that the patient be placed under full
anesthesia. Furthermore, placement of a chest tube is typically
required to reinflate the lung, often requiring a hospitalization
for a couple of days.
[0007] U.S. Pat. No. 5,865,791, to Whayne et. al. describes a
transvascular approach for closing the left atrial appendage.
Access is gained via the venous system, typically through a femoral
vein, a right internal jugular vein, or a subclavian vein, where a
catheter is advanced in an antegrade direction to the right atrium.
The intra-atrial septum is then penetrated, and the catheter passed
into the left atrium. The catheter is then positioned in the
vicinity of the left atrial appendage which is then fused closed,
e.g., using radiofrequency energy, other electrical energy, thermal
energy, surgical adhesives, or the like. Whayne et. al. further
describes a thoracoscopic procedure where the pericardium is
penetrated through the rib cage and a lasso placed to tie off the
neck of the left atrial appendage. Other fixation means described
include sutures, staples, shape memory wires, biocompatible
adhesives, tissue ablation, and the like. The transvascular
approach suggested by Whayne et. al. is advantageous in that it
avoids the need to penetrate the patient's chest but suffers from
the need to penetrate the intra-atrial septum, may not provide
definitive closure, requires entry into the left atrial appendage
which may dislodge clot and requires injury to the endocardial
surface which may promote thrombus formation. A thorascoscopic
approach which is also suggested by Whayne et. al. suffers from the
same problems as the thoracoscopic approach suggested by
Johnson.
[0008] For all these reasons, it would be desirable to provide
improved and alternative methods and procedures for performing
minimally invasive closure of the left atrial appendage. Such
methods and procedures will preferably be capable of being
performed on patients who have received only a local anesthetic and
whose hearts have not been stopped. It would be further desirable
to provide methods and procedures which approach the left atrial
appendage without the need to perform a thoracotomy (penetration
through the intracostal space) or the need to perform a transeptal
penetration and/or perform the procedure within the left atrium or
left atrial appendage. More specifically, it would be preferable to
provide methods and procedures which permitted access to the
pericardial space from the xiphoid region of a patient's chest. In
addition to the improved and alternative methods and procedures, it
would be desirable to provide specialized instruments, devices, and
systems for accessing a region over a patient's left atrial
appendage from a sub-xiphoid access point to permit closure of the
left atrial appendage.
[0009] At least some of these objectives will be met by the
inventions described herein below.
Description of the Background Art
[0010] U.S. Pat. Nos. 5,306,324 and 5,865,791 have been described
above. U.S. Pat. No. 3,496,932 and PCT publication WO 98/05289
describe methods and apparatus which employ a sub-xiphoid approach
for direct cardiac massage.
SUMMARY OF THE INVENTION
[0011] The present invention provides alternative and improved
methods and apparatus for closing a left atrial appendage of a
patient, particularly a patient at risk of occlusive stroke
resulting from emboli released from the left atrial appendage. The
most likely patient population for the procedures will be patients
suffering from atrial fibrillation which can result in clot and
thrombus generation in the left atrial appendage, as described
above. The methods and apparatus of the present invention permit
procedures to be performed on a conscious sedated patient, often in
an ambulatory surgical setting where the patient may be released
shortly after the procedure is completed. In particular, the
methods and apparatus of the present invention eliminates the need
for a large incision and division of the sternum, i.e., median
sternotomy. The present invention further eliminates the need to
take down (deflate) a lung to access a left atrial appendage, as is
usually required in thoracoscopic procedures performed via
intracostal access.
[0012] The methods of the present invention will be performed in a
minimally invasive manner, i.e., where access to the pericardial
space overlying the patient's left atrial appendage is accomplished
through percutaneous penetrations through the patient's skin.
Rather than passing through the rib cage, as with prior
thoracoscopic techniques, the present invention relies on a
"sub-xiphoid" approach where the percutaneous penetration is first
made beneath the rib cage, preferably between the xiphoid and
adjacent costal cartilage, and an atrial appendage closure tool
advanced through the penetration, over the epcardial surface (in
the pericardial space) to reach a location adjacent to the exterior
of the left atrial appendage. The closure tool can then be used to
close the left atrial appendage to prevent the formation of clot
and the release of emboli from the atrium.
[0013] Closure can be effected in a variety of ways. It is
presently preferred to position a loop of material, such as suture,
wire, mesh, tape, or the like, over the appendage and cinch the
loop tighter to close the interior of the appendage. A variety of
alternative closure techniques would also find use, including
suturing (using remotely actuated, suturing instruments), stapling,
clipping, fusing, gluing, clamping, riveting, or the like. Such
closure will generally be intended to be permanent, i.e., it will
remain indefinitely after the closure tool is removed, but in some
instances could be reversible, i.e., the left atrial appendage
could be reopened on a subsequent procedure.
[0014] Thus, a method according to the present invention for
closing a left atrial appendage of a patient's heart comprises
positioning a closure instrument through a percutaneous passage
beneath the rib cage, over an epicardial surface, and adjacent to
the left atrial appendage. The left atrial appendage is then
closed, usually using one of the techniques described above. The
positioning step may comprise making an incision usually between a
costal cartilage and a xiphoid of the patient, establishing a tract
beneath the rib cage. Alternatively the incision may be made
superficial to the xiphoid or sternum after which a tract is made
through the rib cage to the pericardial space, and will preferably
include placing an access sheath through the incision into the
pericardial space. The incision may be made using a scalpel or
other conventional surgical tool, but could also be made using a
trocar and cannula assembly, such as those used in laparoscopic
surgery, where the trocar could then be removed leaving the cannula
in place as the sheath of the present invention. Use of a trocar
and cannula may be less preferred, however, since there is an
increased risk of injuring the heart if the trocar and cannula
assembly is introduced in a blind fashion.
[0015] A closure instrument is then introduced through the sheath
into the pericardial space, and over an epicardial surface to the
exterior of the left atrial appendage, as described, above.
Preferably, a distal end of the tool will be introduced into an
atrioventricular groove which lies just beneath the atrial
appendage.
[0016] Preferably, once the closure tool has been introduced,
advancement and positioning can be performed under conventional
imaging techniques, such as fluoroscopic imaging. Often, the
closure tool will include or be compatible with imaging scopes
which may be introduced through the tool. The use of imaging scopes
will be particularly useful during the closure procedure where the
left atrial appendage is manipulated as described in more detail
below. In such instances, it will frequently be desirable to
introduce a saline or other clear fluid into the pericardial space
to facilitate viewing.
[0017] Once the closure tool is properly positioned, closure may be
effected by any of the techniques described above, including
looping, suturing, stapling, clipping, fusing, clamping, riveting,
or the like. Preferably, the closure will be directed at the base
region of the left atrial appendage. Optionally, closing the
appendage may further comprise grasping the exterior of the left
atrial appendage prior to the actual closing step. Grasping will
typically be performed with the conventional grasping tool. As
described below, a preferred closure technique is to first grasp
the exterior of the left atrial appendage with a grasping tool and
subsequently advance a closure loop over the tool on to the
exterior of the appendage. A closure loop may then be cinched or
otherwise closed or allowed to close, and the tools removed.
[0018] A variety of specific instruments, devices, and systems may
be devised for performing the methods of the present invention. An
exemplary device for closing a left atrial appendage according to
the methods of the present invention is described in detail in the
descriptions that follow. The device comprises a shaft having a
proximal end and a distal end, where the distal end is adapted to
percutaneously enter the pericardial space, be advanced over an
epicardial surface, and then approach the exterior of the left
atrial appendage. Preferably, the shaft has a length in the range
from 10 cm to 40 cm, a width in the range from 2 mm to 20 mm, and a
thickness in the range from 1 mm to 10 mm. Usually, the shaft will
be curved over its length to be compatible with the curvature of
the heart. The shaft may include a means to alter the curvature to
accommodate variations in anatomy. Similarly, the device may
preferably include a crescent-shaped cross-section to also conform
to the shape of the exterior of the heart. The device will carry a
mechanism or means for closing the left atrial appendage when the
distal end of the shaft is positioned adjacent to the appendage.
Usually, the closure mechanism will be introducable through one or
more lumens formed in the shaft. In a particularly preferred
configuration, the distal end of the shaft will be configured to
lie within the atrioventricular groove of the heart, and at least
one lumen through the shaft will have an exit port spaced inwardly
from the distal end of the shaft by a distance in the range from
0.5 cm to 5 cm. In this way, the port will be positioned properly
to access the free end of the atrial appendage for performing the
closing procedures. In addition, the shaft may have one or more
additional lumens (for a total of two, three, or more lumens
through the shaft) in order to provide additional capabilities,
including introduction and use of a viewing scope, infusion and
perfusion of fluids, particularly the infusion of saline to
facilitate viewing. Optionally, the lumens can be used to introduce
an anesthetic agent, such as lidocaine, in order to reduce pain or
to introduce an anti-arrhythmic agent to reduce myocardial
irritability.
[0019] The present invention still further comprises kits including
the closure devices just described. The kits will further include
instructions for use according to the methods described above, and
optionally further include packaging for holding all components of
the kit together. Additionally, the kits may include the access
sheath which is placed through the percutaneous penetration tracks
as the pericardial space. The access sheath may be in the form of a
trocar and cannula assembly, although this will usually not be
preferred.
BRIEF DESCRIPTION OF THE DRAWINGS
[0020] FIG. 1 is an anterior view of a heart illustrating the
position of the left atrial appendage relative to the remaining
structures of the heart.
[0021] FIG. 2 shows the position of the heart in an associated
chest cavity and illustrates a preferred percutaneous access site
for performing the methods of the present invention.
[0022] FIGS. 3 and 3A are perspective views of an exemplary closure
tool useful for performing the methods of the present
invention.
[0023] FIGS. 4A-4C are orthogonal views of the closure device of
FIG. 3.
[0024] FIG. 5 illustrates an access sheath placed percutaneously
into a pericardial space using a sub-xiphoid approach beneath the
rib cage as is preferred in the methods of the present
invention.
[0025] FIGS. 6A-6G illustrate use of the exemplary tool of FIG. 3
in performing the closure of a left atrial appendage according to
the methods of the present invention.
[0026] FIGS. 6H-6J illustrate a modified closure device for
introduction of a balloon expander.
[0027] FIGS. 6K-6N illustrate an alternative protocol for use of
the exemplary tool of FIG. 3 in performing the closure of a left
atrial appendage according to the methods of the present
invention.
[0028] FIGS. 6O and 6P illustrate alternative clip placement
patterns for closing the left atrial appendage according to the
methods of the present invention.
[0029] FIG. 7A-7C illustrate an exemplary clip which may be used in
performing the closure methods of the present invention.
[0030] FIG. 8 illustrates a clip insertion tool useful for placing
the clip of FIGS. 7A-7C according to the methods of the present
invention.
[0031] FIGS. 9A-9C are cross-sectional views of the insertion tool
of FIG. 8 used in placing the clip of FIG. 7A-7C over a left atrial
appendage according to the methods of the present invention.
[0032] FIG. 10 illustrates an exemplary kit including a closure
device and optional components according to the present
invention.
DESCRIPTION OF THE SPECIFIC EMBODIMENTS
[0033] FIG. 1 is an anterior view of a heart illustrating the right
ventricle RV, the left ventricle LV, and the left atrial appendage
LAA. The methods and apparatus of the present invention are
intended to place a closure structure over or otherwise close off
the base region BR of the left atrial appendage. By closing off the
base region BR, the exchange of materials between the left atrial
appendage LAA and the left atrium LA will be stopped. Thus, the
release of emboli from the left atrial appendage into the left
atrium will be stopped.
[0034] Referring now to FIG. 2, the heart is located within the
pericardial space PS located beneath the patient's rib cage RC. The
sternum S is located in the center of the rib cage RC and
terminates at its lower end in the xiphoid X. On either side of the
xiphoid are the costal cartilage CC, and the percutaneous access
points for performing the procedures of the present invention will
be located beneath the rib cage RC, and preferably between the
xiphoid X and an adjacent costal cartilage CC, preferably at the
access location AL shown by a broken line.
[0035] An exemplary tool 10 for performing the methods of the
present invention is illustrated in FIGS. 3, 3A, and 4A-4C. The
tool comprises a shaft 12 having a distal end 14 and a proximal end
16. A handle 18 is preferably attached to the proximal end of the
shaft, and the shaft will have a curved profile in its axial
direction (as best seen in FIG. 4B) and a crescent-shaped
cross-section, as best seen in FIG. 4C. The preferred dimensions of
the shaft are set forth above.
[0036] In the illustrated embodiment, the shaft has three lumens
20, 22, and 24. A first lumen 20 is used for introducing a closure
tool (which may be any of the closure tools described above), while
the second and third lumens (22 and 24, respectively) are used for
introducing a viewing scope and fluids, such as saline or other
clear fluids for improving visualization of the region surrounding
the atrial appendage. In alternative embodiments, the first lumen
20 can still be used for a grasper, while either of the second
lumen 22 and/or third lumen 24 may be used for introducing
alternative closure devices, such as clip appliers, riveting
devices, fusing devices, suturing devices, stapling devices, or the
like. In a particular embodiment shown below, either or both of the
lumens 22 and 24 may be used to advance a clip over the left atrial
appendage as the appendage is being grasped by a grasper, such as
the one shown in FIG. 3.
[0037] While the closure tool may have any of a wide variety of
designs, the presently preferred tool is shown in FIG. 3A. The tool
comprises a grasper 30 and a capture loop 32. Capture loop 32 is
attached to a manipulation wire 34 which permits the loop 32 to be
advanced over the forward end of the grasper to encircle and close
the left atrial appendage, as will be described in more detail
below. The grasping tool 36 may be manipulated using a thumb guide
40, while the capture loop 32 may be manipulated using a second
thumb guide 42, both of which are located on the handle 18.
[0038] The lumens 20, 22, and 24, terminate in exit ports 50, 52,
and 54, best seen in FIG. 4A. The exit ports are located proximally
of the distal end 14 of the shaft 12. The shaft is generally
thinned in the region between the exit ports and the distal tip,
facilitating the introduction of the distal tip into the
atrioventricular groove, as described in more detail below. The
exit ports are located a sufficient distance behind the distal tip
of the shaft so that they will be generally located adjacent to the
free end of the left atrial appendage when the tip is located in
the atrioventricular groove.
[0039] The methods of the present invention may be performed in an
ambulatory surgical setting. Typically, a sedated patient is taken
to a facility having fluoroscopic imaging capabilities. The area
overlying the xiphoid and adjacent costal cartilage, is prepared
and draped using standard techniques. A local anesthetic is then
administered and a skin incision, usually about 2 cm in length
made, at the area shown in FIG. 2. The percutaneous penetration
passes beneath the costal cartilage, and a sheath 100 (FIG. 5) is
introduced into the pericardial space PS. The pericardial space PS
is then irrigated with saline, preferably with a saline-lidocaine
solution to provide additional anesthesia and reduce the risk of
irritating the heart. The closure device 10 is then introduced
through the sheath 100 into the pericardial space and advanced over
the epicardium to the atrioventricular groove AVG (as shows in FIG.
6A and FIG. 6B). The grasping tool 30 is then advanced distally
from the tool 10 so that it can grasp the free end of the left
atrial appendage LAA, as shown in FIG. 6C. A slight tension can be
applied on the left atrial appendage LAA as the capture loop 32 is
advanced over the grasper 30 (FIG. 6D), and on to the left atrial
appendage LAA, as shown in FIG. 6E. The loop may then be cinched,
as shown in FIG. 6F, and the tool 10 withdrawn leaving the closure
loop in place, as shown in FIG. 6G. The interior of the left atrial
appendage LAA is thus isolated from the interior of the left atroi,
so that thrombus and other emboli cannot be released into blood
circulation.
[0040] Optionally, a portion of the parietal pericardium may be
further separated from the epicardial surface and the left atrial
appendage prior to closing the appendage. Increasing the distance
between the parietal and visceral pericardium, i.e., the
pericardial Space, creates a working and viewing space that
facilitates subsequent manipulation and closure of the atrial
appendage. As shown in FIGS. 6H-6J, a modified closure device 100
having an additional lumen 102 is introduced so that its distal end
104 enters the atrioventricular groove AVG, as described
previously. A balloon expander 110 may then be introduced through
the lumen 102, and the balloon expanded to raise the pericardium,
as shown in FIG. 6I. The grasper 30 (or other closure instrument)
may then be introduced through other lumens, as previously
described. The working space created by the balloon greatly
simplifies manipulation and positioning of the graspers 30 so that
they can be used to capture the atrial appendage and close it as
described previously. Further separating the parietal and visceral
pericardia to create the working space is a particular advantage
when a viewing scope is introduced to the working area to
facilitate manipulation of the grasper 30 and any other tools which
may be used.
[0041] Referring now to FIGS. 6K-6N, the closure tool 10 is
illustrated in a method for introducing a clip 200 in accordance
with the principles of the present invention. The closure tool 10
is introduced to the left atrial appendage LAA as described in
above in connection with FIGS. 6A and 6B. Once in place, the clip
200 may be introduced through any of the available lumens in the
device, typically using a pusher 202. The clip 200 will be
configured so that it opens as it emerges from the closure tool 10
and can be advanced over the free distal end of the left atrial
appendage LAA, as shown in FIG. 6L. The clip 200 may then be closed
over the appendage, as shown in FIG. 6N. The clip 200 may be
self-closing or may require a mechanical or heat-actuated closure
mechanism. Once in place, as shown in FIG. 6N, the closure tool 10
can be removed. Frequently, it will be desirable to introduce
multiple clips 200, as shown in FIG. 6O. Alternatively, a larger
clip 208 can be introduced transversely over the left atrial
appendage LAA, as shown in FIG. 6P.
[0042] Referring now to FIGS. 7A-7C, an exemplary clip 300 for use
in the methods of the present invention will be described. The clip
300 has a generally U-shaped profile, as best seen in FIG. 7A,
optionally having a serpentine or zag-zag profile on at least one
of the legs of the clip. As illustrated, a series of peaks and
valleys 302 is provided on an "upper" leg of the clip. The clip 300
further includes a hinge region 304 which has a narrowed width to
facilitate introduction through a introducer catheter 400, as shown
in FIG. 8. Introducer catheter 400 has a I-shaped lumen 402 which
receives the clip 300 so that the upper leg and lower leg of the
clip are held in an open configuration in upper and lower tracks of
the lumen, as described below in connection with FIGS. 9A-9C.
Optionally, the catheter 400 may include a radiopaque marker 404 to
permit orientation under fluoroscopic imaging (so the position can
confirm that the clip is in the proper vertical orientation when
being placed). A pusher 408 is provided having a I-shaped distal
end 410 which is received in the I-shaped lumen 402 in order to
advance and eject the clip from the catheter.
[0043] Referring now to FIGS. 9A-9C, the clip 300 is held in the
lumen 402 of catheter 400 with the legs of the clip held open. A
pusher 408 can be advanced so that end 410 engages the hinge region
304 of the clip, allowing it to be advanced out of the distal end
of the catheter, as shown in FIG. 9B. As the clip 300 emerges, it
remains in an open configuration so that it can be advanced ever a
free distal end of the left atrial appendage LAA, as shown in FIG.
9B. Once the clip 300 is fully advanced and released from the
catheter 400, as shown in FIG. 9C, the clip will close over the
left atrial appendage LAA to hold the appendage closed in
accordance with the principles of the present invention.
[0044] Referring now to FIG. 10, kits according to the present
invention comprise a closure tool, such as closure tool 10
described above. Optionally, the kits may comprise an access sheath
120 and will include instructions for use IFU setting forth any of
the methods described above. Usually, all components of the kit
will be packaged together in an enclosure 140, such as a pouch,
tray, box, tube, or other conventional surgical package capable of
maintaining the components in a sterile condition. It will be
appreciated that any kit containing instructions for use setting
forth the methods of the present invention will be part of the
present invention. Whether or not the kits include a closure device
which is similar to FIG. 10 is not necessary.
[0045] While the above is a complete description of the preferred
embodiments of the invention, various alternatives, modifications,
and equivalents may be used. Therefore, the above description
should not be taken as limiting the scope of the invention which is
defined by the appended claims.
* * * * *